Shares of HealthEquity (HQY) plummeted 13.73% in after-hours trading on Tuesday following the release of the company's fourth-quarter earnings report and fiscal year 2026 guidance, both of which fell short of analysts' expectations.
The health savings account (HSA) administrator reported adjusted earnings per share of $0.69 for the fourth quarter, missing the analyst consensus estimate of $0.72. While this represents a 9.52% increase from the same period last year, it wasn't enough to satisfy investor expectations. Revenue for the quarter came in at $311.8 million, surpassing the $306.1 million estimate, but the bottom-line miss overshadowed this achievement.
Adding to investor concerns, HealthEquity's outlook for fiscal year 2026 disappointed Wall Street. The company expects adjusted earnings per share between $3.57 and $3.74, with the midpoint falling below the $3.71 analysts had projected. Similarly, the revenue guidance of $1.28 billion to $1.31 billion also came in slightly below market expectations of $1.30 billion. The company's Adjusted EBITDA outlook of $525 million to $545 million for FY2026 further contributed to the negative sentiment.
Despite reporting growth in health savings accounts and total assets under management, the weaker-than-anticipated earnings and outlook appear to have spooked investors, leading to the significant after-hours sell-off. The market's reaction suggests concerns about HealthEquity's ability to maintain its growth trajectory and profitability in the face of potential headwinds in the healthcare and benefits administration industry.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.